Finance

Beta
Lists
PRLD:NASDAQ
Prelude Therapeutics Inc
$3.94
-3.43%
(-0.14) 1D
Jun 5, 10:04:32 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRLD...
Open
$4.05
High
$4.06
Low
$3.90
Mkt. cap
315.40M
Avg. vol.
456.32K
Volume
5.99K
52-wk high
$5.54
52-wk low
$0.75
EPS
-$1.00
Beta
1.00
Shares outstanding
64.92M
No. of employees
79
Open
$4.05
High
$4.06
Low
$3.90
Mkt. cap
315.40M
Avg. vol.
456.32K
Volume
5.99K
52-wk high
$5.54
52-wk low
$0.75
EPS
-$1.00
Beta
1.00
Shares outstanding
64.92M
No. of employees
79
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to PRLD in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PRLD in the last 3 months.
Highest
Current $3.94
$9.00 (+128.43%)
Average
$7.67 (+94.67%)
Lowest
$6.00 (+52.28%)
News stories
From sources across the web
About Prelude Therapeutics Inc
CEO-
Employees79
Founded2016
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websitepreludetx.com
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.13 / -$0.27
+51.25%beat
Revenue / Est. (USD)
4.58M / 0.00
+∞%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
6.50M
5.64M
4.58M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.78M
21.71M
16.79M
13.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.41M
5.21M
4.90M
5.16M
Operating expense
32.19M
26.92M
21.69M
18.76M
Total operating expenses
32.19M
26.92M
21.69M
18.76M
Operating income
-32.19M
-20.42M
-16.05M
-14.18M
Other non operating income
963.00K
693.00K
891.00K
3.79M
EBT including unusual items
-31.23M
-19.72M
-16.46M
-10.38M
EBT excluding unusual items
-31.23M
-19.72M
-15.16M
-10.38M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-31.23M
-19.72M
-16.46M
-10.38M
Net profit margin
-
-303.46%
-291.79%
-226.75%
Earnings per share
-0.41
-0.26
-0.20
-0.13
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-31.76M
-19.99M
-15.63M
-13.79M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer